BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 34533582)

  • 1. Autoimmune-mediated renal disease and hypertension.
    Boesen EI; Kakalij RM
    Clin Sci (Lond); 2021 Sep; 135(17):2165-2196. PubMed ID: 34533582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing autoimmunity protects against the development of hypertension and renal injury.
    Mathis KW; Wallace K; Flynn ER; Maric-Bilkan C; LaMarca B; Ryan MJ
    Hypertension; 2014 Oct; 64(4):792-800. PubMed ID: 25024282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure and albuminuria in a female mouse model of systemic lupus erythematosus: impact of long-term high salt consumption.
    Dent EL; Broome HJ; Sasser JM; Ryan MJ
    Am J Physiol Regul Integr Comp Physiol; 2020 Oct; 319(4):R448-R454. PubMed ID: 32813539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal hemodynamic changes in a female mouse model of systemic lupus erythematosus.
    Dent EL; Taylor EB; Sasser JM; Ryan MJ
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1074-F1085. PubMed ID: 32150445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune Disease-Associated Hypertension.
    Wolf VL; Ryan MJ
    Curr Hypertens Rep; 2019 Feb; 21(1):10. PubMed ID: 30712132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics for the treatment of autoimmune renal diseases.
    Holdsworth SR; Gan PY; Kitching AR
    Nat Rev Nephrol; 2016 Apr; 12(4):217-31. PubMed ID: 26949177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous Tim-1 promotes severe systemic autoimmunity and renal disease MRL-Fas(lpr) mice.
    Nozaki Y; Kitching AR; Akiba H; Yagita H; Kinoshita K; Funauchi M; Matsumura I
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1210-21. PubMed ID: 24623145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An impaired neuroimmune pathway promotes the development of hypertension in systemic lupus erythematosus.
    Mathis KW
    Am J Physiol Regul Integr Comp Physiol; 2015 Nov; 309(9):R1074-7. PubMed ID: 26084696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure control over time in childhood-onset systemic lupus erythematous.
    Avar Aydin PO; Shan J; Brunner HI; Mitsnefes MM
    Lupus; 2018 Apr; 27(4):657-664. PubMed ID: 29301473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of N-acetyl-seryl-asparyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosus.
    Nakagawa P; Masjoan-Juncos JX; Basha H; Janic B; Worou ME; Liao TD; Romero CA; Peterson EL; Carretero OA
    Physiol Rep; 2017 Jan; 5(2):. PubMed ID: 28126732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the Genetic Code of Autoimmune Kidney Diseases.
    Huang SU; Kulatunge O; O'Sullivan KM
    Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence and Role of Microbial Factors in Autoimmune Kidney Diseases: A Systematic Review.
    Kronbichler A; Kerschbaum J; Mayer G
    J Immunol Res; 2015; 2015():858027. PubMed ID: 26078982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal inflammation, autoimmunity and salt-sensitive hypertension.
    Rodríguez-Iturbe B; Franco M; Tapia E; Quiroz Y; Johnson RJ
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):96-103. PubMed ID: 21251049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease.
    Taylor EB; Barati MT; Powell DW; Turbeville HR; Ryan MJ
    Hypertension; 2018 Apr; 71(4):719-728. PubMed ID: 29378858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects.
    Porta C; Caporali R; Montecucco C
    Haematologica; 1999 Mar; 84(3):260-9. PubMed ID: 10189393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicles Tune the Immune System in Renal Disease: A Focus on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, Thrombotic Microangiopathy and ANCA-Vasculitis.
    Mazzariol M; Camussi G; Brizzi MF
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells in immune-mediated renal disease.
    Ghali JR; Wang YM; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2016 Feb; 21(2):86-96. PubMed ID: 26206106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex and gender differences in hypertensive kidney injury.
    Sullivan JC; Gillis EE
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1009-F1017. PubMed ID: 28724606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen in cardiovascular disease during systemic lupus erythematosus.
    Gilbert EL; Ryan MJ
    Clin Ther; 2014 Dec; 36(12):1901-1912. PubMed ID: 25194860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of hypertension in autoimmune rheumatic diseases.
    Taylor EB; Wolf VL; Dent E; Ryan MJ
    Br J Pharmacol; 2019 Jun; 176(12):1897-1913. PubMed ID: 30714094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.